29 employees
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
2018
$60M
from 1 investors over 1 rounds
Rheos Medicines raised $60M on March 22, 2018
Investors: Third Rock Ventures